Capricor Therapeutics

Large employer

29 open jobs

Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The company's lead program is Deramiocel (CAP-1002), a cell therapy in late-stage development for Duchenne muscular dystrophy, and it is developing its proprietary StealthX™ exosome platform for targeted delivery and vaccinology.